Precision medicine is the key to the future of healthcare.
At Primo, our mission is to continuously drive its evolution.
As a PIC/S GMP-certified facility, Primo is equipped with advanced technology including the GEHC PETtrace 800 Cyclotron, dedicated radiopharmaceutical laboratories, and ISO-5/ISO-7 cleanrooms.
We currently operate 3 production lines under a ‘One-Drug-One-Line’ dedicated manufacturing model to ensure rigorous quality control.
Our infrastructure excels in meeting small-batch, diversified demands while maintaining the scalability for large-scale commercial production.
Automation ensures process consistency and superior product quality.
Value of Automation:
Ultimate Stability: Precision through automated control, ensuring every dose adheres to the most stringent quality standards.
Radiation Protection & Safety:Automated workflows significantly reduce human exposure to radioactive materials, substantially elevating the safety standards of our operational environment.
Efficiency Maximization: Advanced automated monitoring allows for precise control of production pacing, delivering consistently stable and high-purity pharmaceutical products.
0
↑
Radiopharmaceutical R&D & Manufacturing
Manufacturing Process
Drug Patents & Publications
種
TFDA IND Approval Achieved
Clinical Research & Multi-Project Drug Manufacturing
The evolution of precision medicine is Primo’s eternal pursuit. Entrusted with the mission to safeguard health, we leverage our independent R&D and automated manufacturing capabilities to ensure the most advanced diagnostic and therapeutic radiopharmaceuticals remain available in Taiwan.
Driven by data and defined by quality, we are dedicated to bringing the dawn of precision medicine to families in need.